Melanoma Among Adult Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study

S Seth J. Rotz (Lillian R. Meacham, MD, Children's Healthcare of Atlanta/Emory University, Atlanta, GA, Tyler G. Ketterl, MD, MS, Seattle Children's Hospital/University of Washington, Seattle, WA, Kari L. Bjornard, MD, MPH, St Jude Children's Research Hospital, Memphis, TN, Leena Nahata, MD, Nationwide Children's Hospital/The Ohio State University College of Medicine, Columbus, OH, Veronica Gomez-Lobo, MD, Eunice Kennedy Shriver National Institute of Child Health and Human Development/National Institute of Health, Bethesda, MD, Allison G. Close, MD, MS, Helen DeVos Children's Hospital/Michigan State University, Grand Rapids, MI, Seth J. Rotz, MD, Cleveland Clinic/Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, Maggie L. Dwiggins, MD, MS, Washington University in Saint Louis, St Louis, MO, Holly R. Hoefgen, MD, Washington University School of Medicine, St Louis, MO, Anthony Kayiira, MD, MSc, MMed, EMB, Uganda Cancer Institute/Uganda Childhood Cancer Foundation, Kampala, Uganda, Marry van den H...) K Kayla Stratton (Fred Hutchinson Cancer Center, Seattle, Washington, United States) W Wendy M. Leisenring (Fred Hutchinson Cancer Center, Seattle, WA) S Susan A. Smith (Constance A. Owens, PhD, Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX; Ethan B. Ludmir, MD, Department of Gastrointestinal Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX; Qi Liu, PhD, and Weiyu Qiu, PhD, Department of Public Health Sciences, University of Alberta, Edmonton, AB, Canada; Aashish C. Gupta, MS, Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX; Susan A. Smith, MPH, and Bastien Rigaud, PhD, Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX; Kristy K. Brock, PhD, Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX; James E. Bates, MD, Department of Radiation Oncology, Winship Cancer Institute, ...) R Rebecca M. Howell J James E. Bates A Alberto S. Pappo (St. Jude Children's Research Hospital, Memphis, TN) J Joseph P. Neglia G Gregory T. Armstrong L Lucie M. Turcotte

Abstract

PURPOSE Melanoma as a subsequent malignant neoplasm has been described among childhood cancer survivors; however, the risk factors and long-term survival are not well understood. METHODS We assessed incidence, risk factors, and outcomes for melanoma among participants in the Childhood Cancer Survivor Study cohort. Cumulative incidence and standardized incidence ratios (SIRs) were calculated, and multivariable Cox models were used to determine hazard ratios (HRs) and associated 95% CI for melanoma risk factors. Radiation exposure to seven body regions and melanoma status for each of eight regions per survivor were integrated into the Cox model. RESULTS Among 25,716 participants, 177 melanomas developed in 160 survivors (110 invasive, 62 in situ cutaneous, five ocular). The 40-year melanoma cumulative incidence was 1.1% (95% CI, 0.9 to 1.4) for all participants and 1.5% (95% CI, 1.0 to 2.1) among those receiving a cumulative radiation dose of ≥40 Gy. Compared with the general population, the SIR for invasive skin or ocular melanoma was 2.0 (95% CI, 1.6 to 2.4). A cumulative radiation dose of ≥40 Gy to the corresponding body region(s) of the melanoma (HR, 2.0 [95% CI, 1.1 to 3.7]), a cumulative cyclophosphamide equivalent dose of ≥20,000 mg/m 2 (HR, 1.9 [95% CI, 1.1 to 3.6]), and bleomycin exposure (HR, 2.2 [95% CI, 1.2 to 4.1]) were associated with increased cutaneous melanoma. Invasive melanoma at any site was associated with an increased risk of death (HR, 2.4 [95% CI, 1.7 to 3.3]). CONCLUSION Childhood cancer survivors have more than a two-fold increased risk of melanoma compared with the general population, and those with an invasive melanoma have more than a two-fold risk of death. High-dose radiation and alkylating agent exposure, and bleomycin are important risk factors for melanoma and should be considered in future patient guidance and screening.

Article Details

Volume / Issue Vol. 43, Issue 10
Published April 01, 2025
Pages 1219-1228
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (10)

S

Seth J. Rotz

Lillian R. Meacham, MD, Children's Healthcare of Atlanta/Emory University, Atlanta, GA, Tyler G. Ketterl, MD, MS, Seattle Children's Hospital/University of Washington, Seattle, WA, Kari L. Bjornard, MD, MPH, St Jude Children's Research Hospital, Memphis, TN, Leena Nahata, MD, Nationwide Children's Hospital/The Ohio State University College of Medicine, Columbus, OH, Veronica Gomez-Lobo, MD, Eunice Kennedy Shriver National Institute of Child Health and Human Development/National Institute of Health, Bethesda, MD, Allison G. Close, MD, MS, Helen DeVos Children's Hospital/Michigan State University, Grand Rapids, MI, Seth J. Rotz, MD, Cleveland Clinic/Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, Maggie L. Dwiggins, MD, MS, Washington University in Saint Louis, St Louis, MO, Holly R. Hoefgen, MD, Washington University School of Medicine, St Louis, MO, Anthony Kayiira, MD, MSc, MMed, EMB, Uganda Cancer Institute/Uganda Childhood Cancer Foundation, Kampala, Uganda, Marry van den H...

K

Kayla Stratton

Fred Hutchinson Cancer Center, Seattle, Washington, United States

W

Wendy M. Leisenring

Fred Hutchinson Cancer Center, Seattle, WA

S

Susan A. Smith

Constance A. Owens, PhD, Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX; Ethan B. Ludmir, MD, Department of Gastrointestinal Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX; Qi Liu, PhD, and Weiyu Qiu, PhD, Department of Public Health Sciences, University of Alberta, Edmonton, AB, Canada; Aashish C. Gupta, MS, Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX; Susan A. Smith, MPH, and Bastien Rigaud, PhD, Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX; Kristy K. Brock, PhD, Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX; James E. Bates, MD, Department of Radiation Oncology, Winship Cancer Institute, ...

R

Rebecca M. Howell

J

James E. Bates

A

Alberto S. Pappo

St. Jude Children's Research Hospital, Memphis, TN

J

Joseph P. Neglia

G

Gregory T. Armstrong

L

Lucie M. Turcotte